Lila Sciences' Swollen First Round, and Other Biofinancings

Lila Sciences' swollen first round, and other biofinancings

AI-powered autonomous lab firm Lila Sciences upsizes its Series A to $350m, heading a bumper week for new biotech financings.

Lila Sciences, which uses AI to develop novel drugs and materials, raised $115M at a $1.3B valuation, bringing its Series A to $350M and total funding to $550M

Top news and commentary for technology's leaders, from all around the web.

AI Science Factory Company Lila Announces Close of $350M Series A, with NVIDIA Backing

Oct. 17, 2025 — Lila Sciences has announced the close of its $350M Series A, bringing Lila’s total capital raised to $550M. The company said it is using this financing to accelerate the buildout of its AI science factories and bring its “scientific superintelligence platform” to the scientifi c community. Lila Sciences emerged from two […] The post AI Science Factory Company Lila Announces Close of $350M Series A, with NVIDIA Backing appeared fi…

Lila Sciences raises $350M to build scientific superintelligence platform

Lila Sciences raises $350M to build scientific superintelligence platform | Mobi Health News Skip to main content […] Source: MobiHealthnews → Lila Sciences raises $350M to build scientific superintelligence platform The post Lila Sciences raises $350M to build scientific superintelligence platform appeared first on Mediformatica.